Risk of venous thrombosis with hormone replacement therapy.
Scarabin
P Y
PY
D000279:Administration, Cutaneous; D000284:Administration, Oral; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D012306:Risk; D013924:Thrombophlebitis / Q000139:chemically induced*
D004967:Estrogens